Breaking News

Axplora Granted cGMP Approval from AIFA for Extended Production Capacity

Designed to produce HPAPI and steroid batches up to 300 kg.

Axplora, a partner to pharma companies and biotechs for complex APIs, received the cGMP approval from AIFA (national public body regulating medicines for human use in Italy) for the first line of its new Farmabios’ production unit, expanding large scale manufacturing capabilities for HPAPIs and Steroids. In a statement, the company said that this is a key milestone for the Farmabios, Gropello Cairoli site, reinforcing its manufacturing services with a high containment system up to OEB 5, a cr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters